Summary

The global sinusitis treatment market is expected to grow at a significant rate of around 5% during the forecast period. Sinusitis is a common condition in which the lining of the sinuses becomes inflamed. It's usually caused by a viral or bacterial infection. Allergic infections such as allergic rhinitis, asthma, and hay fever, as well as smoking and a weakened immune system, are considered the important factors that can cause sinusitis. The rising incidences of these diseases coupled with the increasing number of sinusitis cases attributed to the rise of the sinusitis treatment market. For instance, as per the CDC, as of 2020, 8.4% of people over the age of 18 have asthma, and 5.8% of children have it.

Olympus Corporation; Medtronic; Stryker; Cipla Inc.; Dr. Reddy’s Laboratories Ltd; Sanofi; Aurobindo Pharma; Intersect ENT, Inc.; Smith+Nephew; and Novartis AG are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
“Amongst Diseases, acute sinusitis category to witness higher CAGR during the forecast period”
Based on the disease, the market has been categorized into acute sinusitis, sub-acute sinusitis, and chronic sinusitis. Among them, the acute sinusitis category to witness higher CAGR during the forecast period. The rising awareness about the early diagnosis and treatment of the disease attributing to the rapid growth of the acute sinusitis segment.

“Amongst Treatment, surgery segment to hold a significant share in the market in 2020”
Based on the treatment, the market has been categorized into analgesics, antihistamines, corticosteroids, antibiotics, and surgery. Among them, the surgery segment holds a considerable share of the market. Among them, the surgeries segment is expected to grow at a significant CAGR during the forecast period. The presence of a large number of patients having nasal polyps, nasal obstructions, and nasal tumors that hinders the treatment of sinusitis are the main reasons for the growth of the segment. For instance, as per the American Academy of Allergy Asthma & Immunology, about 20% of patients with chronic rhinosinusitis have nasal polyps and benign growths in the nasal cavities that are thought to originate from the ethmoid sinuses.

“Asia Pacific to witness the fastest growth in the market”
Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. The increasing number of cases of sinusitis along with the rising healthcare investments attributes to the market growth of sinusitis treatment in the region. For instance, according to the National Institute of Allergy and Infectious Diseases (NIAID), an estimated 134 million Indians suffer from chronic sinusitis.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
The global sinusitis treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

ページTOPに戻る

Table of Contents